All Reports Events Blogs Videos
Showing 339 results
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • State of the Market
    June 22, 2026

    Life sciences enterprises are rethinking Customer Relationship Management (CRM) services as commercial transformation becomes more complex, platform-driven, and outcome-focused. As organizations migrate to cloud-based CRM environments, expand their Veeva and Salesforce ecosystems, and navigate increasingly complex…
  • In the News
    May 14, 2026

    "Shared data allows the life sciences company to view the customer consistently across the organization, which means everyone is trying to drive the same outcomes for the customer instead of having a different view of the…
  • Blog
    May 13, 2026

    Since the launch of Claude Cowork, narratives suggesting that Artificial Intelligence (AI) will replace Software-as-a-Service (SaaS) platforms have gained significant momentum. We previously referred to this trend as the SaaSocalypse.  With the rise in vibe-coding and the rapidly advancing developer tools, many assume enterprises will increasingly build their own…
  • See Us At
    May 08, 2026

    Join Ankit Gupta, Vice President at Everest Group, to explore how organizations can align stakeholders, define measurable success, and minimize value leakage to drive more effective transformation outcomes. Register now Key points to explore: Defining transformation…
  • Roundtable
    April 16, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Thursday, May 07, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Blog
    April 10, 2026

    For years, the software and services industries operated within a clear division of roles: software defined what could be done by codifying capabilities and workflows, while services determined how it was implemented and operated at scale through human effort.  Growth for tech services firms scaled predictably with…
  • Blog
    April 09, 2026

    Veeva’s acquisition of Ostro reflects a shift in how life sciences engagement is evolving toward a model that is connected, conversational, and increasingly pull-based.  This shift matters because the industry’s commercial engagement model continues to face challenges. Life sciences…
  • Roundtable
    March 31, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Tuesday, April 14, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Thematic Report
    March 26, 2026

    Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise…
  • Blog
    March 24, 2026

    Pharma Customer Relationship Management (CRM) is no longer a winner-takes-all market. For years, pharma CRM decisions were relatively straightforward, not because enterprises lacked strategic intent, but because the market offered limited real choice. That is now changing.  Since the onset of the COVID-19…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Blog
    Feb. 27, 2026

    Partnership announcements between Systems Integrators (SIs) and frontier Artificial Intelligence (AI) platforms such as Anthropic and OpenAI are accelerating. The pattern matters more than the press releases. It signals a new ecosystem taking shape: one that could reshuffle the services industry in ways that feel uncomfortably familiar. …
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Blog
    Feb. 11, 2026

    For decades, Systems Integrators (SIs) have built their businesses around scale, of talent, delivery capacity, and execution rigor. This model aligned well with an enterprise environment where value creation was closely tied to human effort, predictable workflows, and linear…
  • Viewpoint
    Jan. 09, 2026

    As pharma enterprises modernize data architectures, automate workflows, and scale AI across the value chain, scientific expertise is becoming essential to realize meaningful outcomes from digital initiatives. Without scientific grounding, digital systems risk producing insights that…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • Blog
    Dec. 30, 2025

    Coforge has announced definitive agreements to acquire Encora from Advent International, Warburg Pincus, and other minority shareholders for an enterprise value of US$2.35 billion. Coforge will fund the US$1.89 billion equity value through a preferential allotment, under which Encora’s shareholders will hold ~20% stake in the…
  • Provider Compendium
    Dec. 19, 2025

    Enterprises worldwide are racing to unlock AI-driven productivity, insight, and growth, but most still run mission-critical applications on legacy, siloed environments that cannot support modern AI pipelines. As priorities shift from cost takeout and cloud adoption…

Items per page